Otsuka Holdings Co ( (JP:4578) ) has provided an update.
Otsuka Holdings Co., Ltd. has announced a strategic move to repurchase and subsequently cancel its own shares, aiming to enhance capital efficiency and return profits to shareholders. This decision, approved by the Board of Directors, involves repurchasing up to 12 million shares, representing 2.23% of the total shares outstanding, with a maximum repurchase price of ¥70 billion. The repurchase will occur between March 19 and April 30, 2025, with the cancellation of these shares scheduled for May 23, 2025. This move is expected to positively impact the company’s financial structure and shareholder value.
More about Otsuka Holdings Co
Otsuka Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of healthcare products. The company is listed on the Prime Market of the Tokyo Stock Exchange and is known for its innovative solutions in the healthcare sector.
YTD Price Performance: -13.09%
Average Trading Volume: 693
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $27.36B
For a thorough assessment of 4578 stock, go to TipRanks’ Stock Analysis page.